{"transactions":[{"id":686929,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":23342,"kind":"person","name":"KOCH KEVIN","position":1,"cik":"0001185829","reported_name":"KOCH KEVIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-14T20:52:31.000Z","date":"2026-08-12","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"1/48th of the shares subject to the option vest each month beginning on September 12, 2026, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":200000,"derivative":{"exercise_price":43.56,"expiration_date":"2036-08-12","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001185829-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000118582926000001/primarydocument.xml","form_type":"4"}},{"id":686928,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":23342,"kind":"person","name":"KOCH KEVIN","position":1,"cik":"0001185829","reported_name":"KOCH KEVIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2026-08-14T20:52:31.000Z","date":"2026-08-12","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Restricted Stock Units (\"RSUs\") granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in four equal annual installments beginning on August 12, 2027."}],"balance_after":100000,"derivative":{"exercise_price":0,"expiration_date":"2036-08-12","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001185829-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000118582926000001/primarydocument.xml","form_type":"4"}},{"id":686927,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":23342,"kind":"person","name":"KOCH KEVIN","position":1,"cik":"0001185829","reported_name":"KOCH KEVIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2026-08-14T20:52:31.000Z","date":"2026-08-12","kind":"exercise","planned":false,"acquired":false,"shares":21875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted Stock Units (\"RSUs\") granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in four equal annual installments beginning on August 12, 2026."}],"balance_after":65625,"derivative":{"exercise_price":0,"expiration_date":"2035-08-12","underlying":"Common Stock","underlying_shares":21875},"source":{"system":"sec-edgar","filing":"0001185829-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000118582926000001/primarydocument.xml","form_type":"4"}},{"id":686926,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":23342,"kind":"person","name":"KOCH KEVIN","position":1,"cik":"0001185829","reported_name":"KOCH KEVIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2026-08-14T20:52:31.000Z","date":"2026-08-12","kind":"exercise","planned":false,"acquired":false,"shares":17969,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted Stock Units (\"RSUs\") granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in four equal annual installments beginning on August 12, 2025."}],"balance_after":35938,"derivative":{"exercise_price":0,"expiration_date":"2034-08-12","underlying":"Common Stock","underlying_shares":17969},"source":{"system":"sec-edgar","filing":"0001185829-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000118582926000001/primarydocument.xml","form_type":"4"}},{"id":686925,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":23342,"kind":"person","name":"KOCH KEVIN","position":1,"cik":"0001185829","reported_name":"KOCH KEVIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-08-14T20:52:31.000Z","date":"2026-08-12","kind":"sale","planned":false,"acquired":false,"shares":913,"price":44.33,"value":40473.29,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs). This sale satisfies the minimum statutory tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary sale by the Reporting Person"},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $44.33 to $44.33, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":52488,"source":{"system":"sec-edgar","filing":"0001185829-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000118582926000001/primarydocument.xml","form_type":"4"}},{"id":686924,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":23342,"kind":"person","name":"KOCH KEVIN","position":1,"cik":"0001185829","reported_name":"KOCH KEVIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-08-14T20:52:31.000Z","date":"2026-08-12","kind":"sale","planned":false,"acquired":false,"shares":8276,"price":43.6582,"value":361315.2632,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs). This sale satisfies the minimum statutory tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary sale by the Reporting Person"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $43.37 to $44.27, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":53401,"source":{"system":"sec-edgar","filing":"0001185829-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000118582926000001/primarydocument.xml","form_type":"4"}},{"id":686923,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":23342,"kind":"person","name":"KOCH KEVIN","position":1,"cik":"0001185829","reported_name":"KOCH KEVIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-08-14T20:52:31.000Z","date":"2026-08-12","kind":"sale","planned":false,"acquired":false,"shares":8782,"price":43.6408,"value":383253.5056,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs). This sale satisfies the minimum statutory tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary sale by the Reporting Person"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $ 43.26 to $44.10, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":61677,"source":{"system":"sec-edgar","filing":"0001185829-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000118582926000001/primarydocument.xml","form_type":"4"}},{"id":686922,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":23342,"kind":"person","name":"KOCH KEVIN","position":1,"cik":"0001185829","reported_name":"KOCH KEVIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-08-14T20:52:31.000Z","date":"2026-08-12","kind":"exercise","planned":false,"acquired":true,"shares":21875,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":70459,"source":{"system":"sec-edgar","filing":"0001185829-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000118582926000001/primarydocument.xml","form_type":"4"}},{"id":686921,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":23342,"kind":"person","name":"KOCH KEVIN","position":1,"cik":"0001185829","reported_name":"KOCH KEVIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-08-14T20:52:31.000Z","date":"2026-08-12","kind":"exercise","planned":false,"acquired":true,"shares":17969,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":48584,"source":{"system":"sec-edgar","filing":"0001185829-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000118582926000001/primarydocument.xml","form_type":"4"}},{"id":1066470,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":23342,"kind":"person","name":"KOCH KEVIN","position":1,"cik":"0001185829","reported_name":"KOCH KEVIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-14T23:42:14.000Z","date":"2025-08-12","kind":"grant","planned":false,"acquired":true,"shares":525000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/48th of the shares subject to the option vest each month beginning on September 12, 2025, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":525000,"derivative":{"exercise_price":13.39,"expiration_date":"2035-08-12","underlying":"Common Stock","underlying_shares":525000},"source":{"system":"sec-edgar","filing":"0001562180-25-005795","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218025005795/primarydocument.xml","form_type":"4"}},{"id":1066469,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":23342,"kind":"person","name":"KOCH KEVIN","position":1,"cik":"0001185829","reported_name":"KOCH KEVIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2025-08-14T23:42:14.000Z","date":"2025-08-12","kind":"grant","planned":false,"acquired":true,"shares":87500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted Stock Units (\"RSUs\") granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in four equal annual installments beginning on August 12, 2026."}],"balance_after":87500,"derivative":{"exercise_price":0,"expiration_date":"2035-08-12","underlying":"Common Stock","underlying_shares":87500},"source":{"system":"sec-edgar","filing":"0001562180-25-005795","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218025005795/primarydocument.xml","form_type":"4"}},{"id":1066468,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":23342,"kind":"person","name":"KOCH KEVIN","position":1,"cik":"0001185829","reported_name":"KOCH KEVIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2025-08-14T23:42:14.000Z","date":"2025-08-12","kind":"exercise","planned":false,"acquired":false,"shares":17968,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted Stock Units (\"RSUs\") granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in four equal annual installments beginning on August 12, 2025."}],"balance_after":53907,"derivative":{"exercise_price":0,"expiration_date":"2034-08-12","underlying":"Common Stock","underlying_shares":17968},"source":{"system":"sec-edgar","filing":"0001562180-25-005795","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218025005795/primarydocument.xml","form_type":"4"}},{"id":1066467,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":23342,"kind":"person","name":"KOCH KEVIN","position":1,"cik":"0001185829","reported_name":"KOCH KEVIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-08-14T23:42:14.000Z","date":"2025-08-12","kind":"sale","planned":false,"acquired":false,"shares":7972,"price":13.3924,"value":106764.2128,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs).  This sale satisfies the minimum statutory tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary sale by the Reporting Person"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $13.36 to $13.49, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":30615,"source":{"system":"sec-edgar","filing":"0001562180-25-005795","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218025005795/primarydocument.xml","form_type":"4"}},{"id":1066466,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":23342,"kind":"person","name":"KOCH KEVIN","position":1,"cik":"0001185829","reported_name":"KOCH KEVIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-08-14T23:42:14.000Z","date":"2025-08-12","kind":"exercise","planned":false,"acquired":true,"shares":17968,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":38587,"source":{"system":"sec-edgar","filing":"0001562180-25-005795","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218025005795/primarydocument.xml","form_type":"4"}},{"id":1156196,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":23342,"kind":"person","name":"KOCH KEVIN","position":1,"cik":"0001185829","reported_name":"KOCH KEVIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2025-05-08T01:10:20.000Z","date":"2025-05-01","kind":"exercise","planned":false,"acquired":false,"shares":10417,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2025-05-01","expiration_date":"2032-05-01","underlying":"Common Stock","underlying_shares":10417},"source":{"system":"sec-edgar","filing":"0001562180-25-003658","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218025003658/primarydocument.xml","form_type":"4"}},{"id":1156195,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":23342,"kind":"person","name":"KOCH KEVIN","position":1,"cik":"0001185829","reported_name":"KOCH KEVIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-05-08T01:10:20.000Z","date":"2025-05-02","kind":"sale","planned":false,"acquired":false,"shares":4276,"price":16.4542,"value":70358.1592,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs).  This sale satisfies the minimum statutory tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $16.07 to $16.84, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":20619,"source":{"system":"sec-edgar","filing":"0001562180-25-003658","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218025003658/primarydocument.xml","form_type":"4"}},{"id":1156194,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":23342,"kind":"person","name":"KOCH KEVIN","position":1,"cik":"0001185829","reported_name":"KOCH KEVIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-05-08T01:10:20.000Z","date":"2025-05-01","kind":"exercise","planned":false,"acquired":true,"shares":10417,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":24895,"source":{"system":"sec-edgar","filing":"0001562180-25-003658","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218025003658/primarydocument.xml","form_type":"4"}},{"id":1212302,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":23342,"kind":"person","name":"KOCH KEVIN","position":1,"cik":"0001185829","reported_name":"KOCH KEVIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-11T20:32:38.000Z","date":"2025-03-07","kind":"exercise","planned":true,"acquired":false,"shares":100,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":41545,"derivative":{"exercise_price":0.18,"exercise_date":"2021-06-13","expiration_date":"2027-08-08","underlying":"Common Stock","underlying_shares":100},"source":{"system":"sec-edgar","filing":"0001562180-25-002293","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218025002293/primarydocument.xml","form_type":"4"}},{"id":1212301,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":23342,"kind":"person","name":"KOCH KEVIN","position":1,"cik":"0001185829","reported_name":"KOCH KEVIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-03-11T20:32:38.000Z","date":"2025-03-07","kind":"sale","planned":true,"acquired":false,"shares":100,"price":30,"value":3000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on September 30, 2024."}],"balance_after":14478,"source":{"system":"sec-edgar","filing":"0001562180-25-002293","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218025002293/primarydocument.xml","form_type":"4"}},{"id":1212300,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":23342,"kind":"person","name":"KOCH KEVIN","position":1,"cik":"0001185829","reported_name":"KOCH KEVIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-03-11T20:32:38.000Z","date":"2025-03-07","kind":"exercise","planned":true,"acquired":true,"shares":100,"price":0.18,"value":18.0,"ownership":{"direct":true},"balance_after":14578,"source":{"system":"sec-edgar","filing":"0001562180-25-002293","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218025002293/primarydocument.xml","form_type":"4"}},{"id":1278800,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":23342,"kind":"person","name":"KOCH KEVIN","position":1,"cik":"0001185829","reported_name":"KOCH KEVIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-07T21:38:11.000Z","date":"2025-02-06","kind":"exercise","planned":true,"acquired":false,"shares":900,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":41645,"derivative":{"exercise_price":0.18,"exercise_date":"2021-06-13","expiration_date":"2027-08-08","underlying":"Common Stock","underlying_shares":900},"source":{"system":"sec-edgar","filing":"0001562180-25-001025","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218025001025/primarydocument.xml","form_type":"4"}},{"id":1278799,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":23342,"kind":"person","name":"KOCH KEVIN","position":1,"cik":"0001185829","reported_name":"KOCH KEVIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-07T21:38:11.000Z","date":"2025-02-05","kind":"exercise","planned":true,"acquired":false,"shares":8636,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":42545,"derivative":{"exercise_price":0.18,"exercise_date":"2021-06-13","expiration_date":"2027-08-08","underlying":"Common Stock","underlying_shares":8636},"source":{"system":"sec-edgar","filing":"0001562180-25-001025","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218025001025/primarydocument.xml","form_type":"4"}},{"id":1278798,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":23342,"kind":"person","name":"KOCH KEVIN","position":1,"cik":"0001185829","reported_name":"KOCH KEVIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-02-07T21:38:11.000Z","date":"2025-02-06","kind":"sale","planned":true,"acquired":false,"shares":900,"price":31.1311,"value":28017.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on September 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $30.03 to $30.1311, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":14478,"source":{"system":"sec-edgar","filing":"0001562180-25-001025","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218025001025/primarydocument.xml","form_type":"4"}},{"id":1278797,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":23342,"kind":"person","name":"KOCH KEVIN","position":1,"cik":"0001185829","reported_name":"KOCH KEVIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-02-07T21:38:11.000Z","date":"2025-02-06","kind":"exercise","planned":true,"acquired":true,"shares":900,"price":13.11,"value":11799.0,"ownership":{"direct":true},"balance_after":15378,"source":{"system":"sec-edgar","filing":"0001562180-25-001025","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218025001025/primarydocument.xml","form_type":"4"}},{"id":1278796,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":23342,"kind":"person","name":"KOCH KEVIN","position":1,"cik":"0001185829","reported_name":"KOCH KEVIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-02-07T21:38:11.000Z","date":"2025-02-05","kind":"sale","planned":true,"acquired":false,"shares":8636,"price":30.0252,"value":259297.6272,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on September 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.14, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":14478,"source":{"system":"sec-edgar","filing":"0001562180-25-001025","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218025001025/primarydocument.xml","form_type":"4"}},{"id":1278795,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":23342,"kind":"person","name":"KOCH KEVIN","position":1,"cik":"0001185829","reported_name":"KOCH KEVIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-02-07T21:38:11.000Z","date":"2025-02-05","kind":"exercise","planned":true,"acquired":true,"shares":8636,"price":0.18,"value":1554.48,"ownership":{"direct":true},"balance_after":23114,"source":{"system":"sec-edgar","filing":"0001562180-25-001025","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218025001025/primarydocument.xml","form_type":"4"}},{"id":1433644,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":23342,"kind":"person","name":"KOCH KEVIN","position":1,"cik":"0001185829","reported_name":"KOCH KEVIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2024-08-14T20:14:40.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":71875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted Stock Units (\"RSUs\") granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in four equal annual installments beginning on August 12, 2024."}],"balance_after":71875,"derivative":{"exercise_price":0,"expiration_date":"2034-08-12","underlying":"Common Stock","underlying_shares":71875},"source":{"system":"sec-edgar","filing":"0001562180-24-006258","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218024006258/primarydocument.xml","form_type":"4"}},{"id":1433643,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":23342,"kind":"person","name":"KOCH KEVIN","position":1,"cik":"0001185829","reported_name":"KOCH KEVIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-14T20:14:40.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":431250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest each month beginning on August 12, 2024, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":431250,"derivative":{"exercise_price":17.05,"expiration_date":"2034-08-12","underlying":"Common Stock","underlying_shares":431250},"source":{"system":"sec-edgar","filing":"0001562180-24-006258","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218024006258/primarydocument.xml","form_type":"4"}},{"id":1528386,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":23342,"kind":"person","name":"KOCH KEVIN","position":1,"cik":"0001185829","reported_name":"KOCH KEVIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2024-05-03T22:26:53.000Z","date":"2024-05-01","kind":"exercise","planned":false,"acquired":false,"shares":10417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"RSUs granted to the reporting person which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in three equal annual installments beginning on May 1, 2023."}],"balance_after":10417,"derivative":{"exercise_price":0,"expiration_date":"2032-05-01","underlying":"Common Stock","underlying_shares":10417},"source":{"system":"sec-edgar","filing":"0001562180-24-003825","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218024003825/primarydocument.xml","form_type":"4"}},{"id":1528385,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":23342,"kind":"person","name":"KOCH KEVIN","position":1,"cik":"0001185829","reported_name":"KOCH KEVIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-05-03T22:26:53.000Z","date":"2024-05-02","kind":"sale","planned":false,"acquired":false,"shares":3152,"price":18.91,"value":59604.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs).  This sale satisfies the minimum statutory tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary sale by the Reporting Person"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $18.68 to $19.12, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":14478,"source":{"system":"sec-edgar","filing":"0001562180-24-003825","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218024003825/primarydocument.xml","form_type":"4"}},{"id":1528384,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":23342,"kind":"person","name":"KOCH KEVIN","position":1,"cik":"0001185829","reported_name":"KOCH KEVIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-05-03T22:26:53.000Z","date":"2024-05-01","kind":"exercise","planned":false,"acquired":true,"shares":10417,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":17630,"source":{"system":"sec-edgar","filing":"0001562180-24-003825","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218024003825/primarydocument.xml","form_type":"4"}},{"id":1801907,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":23342,"kind":"person","name":"KOCH KEVIN","position":1,"cik":"0001185829","reported_name":"KOCH KEVIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-18T23:12:53.000Z","date":"2023-08-17","kind":"grant","planned":false,"acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest each month beginning on September 17, 2023, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":600000,"derivative":{"exercise_price":7.08,"expiration_date":"2033-08-17","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001562180-23-006451","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218023006451/primarydocument.xml","form_type":"4"}},{"id":1906200,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":23342,"kind":"person","name":"KOCH KEVIN","position":1,"cik":"0001185829","reported_name":"KOCH KEVIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2023-05-03T22:25:43.000Z","date":"2023-05-01","kind":"exercise","planned":false,"acquired":false,"shares":10416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"RSUs granted to the Reporting Person which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in three equal annual installments beginning on May 1, 2023."}],"balance_after":20834,"derivative":{"exercise_price":0,"expiration_date":"2032-05-01","underlying":"Common Stock","underlying_shares":10416},"source":{"system":"sec-edgar","filing":"0001562180-23-003918","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218023003918/primarydocument.xml","form_type":"4"}},{"id":1906199,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":23342,"kind":"person","name":"KOCH KEVIN","position":1,"cik":"0001185829","reported_name":"KOCH KEVIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-05-03T22:25:43.000Z","date":"2023-05-02","kind":"sale","planned":false,"acquired":false,"shares":3203,"price":8.9049,"value":28522.3947,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs).  This sale satisfies the minimum statutory tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $8.59 to $9.58, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":7213,"source":{"system":"sec-edgar","filing":"0001562180-23-003918","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218023003918/primarydocument.xml","form_type":"4"}},{"id":1906198,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":23342,"kind":"person","name":"KOCH KEVIN","position":1,"cik":"0001185829","reported_name":"KOCH KEVIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-05-03T22:25:43.000Z","date":"2023-05-01","kind":"exercise","planned":false,"acquired":true,"shares":10416,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10416,"source":{"system":"sec-edgar","filing":"0001562180-23-003918","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218023003918/primarydocument.xml","form_type":"4"}},{"id":2189502,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":23342,"kind":"person","name":"KOCH KEVIN","position":1,"cik":"0001185829","reported_name":"KOCH KEVIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-10T21:41:29.000Z","date":"2022-08-08","kind":"grant","acquired":true,"shares":550000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest each month beginning on September 8, 2022, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":550000,"derivative":{"exercise_price":10.39,"expiration_date":"2032-08-08","underlying":"Common Stock","underlying_shares":550000},"source":{"system":"sec-edgar","filing":"0001562180-22-006025","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022006025/primarydocument.xml","form_type":"4"}},{"id":2284401,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":23342,"kind":"person","name":"KOCH KEVIN","position":1,"cik":"0001185829","reported_name":"KOCH KEVIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2022-05-03T20:14:14.000Z","date":"2022-05-01","kind":"grant","acquired":true,"shares":31250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"RSUs granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in three equal annual installments beginning on May 1, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"RSUs granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in three equal annual installments beginning on May 1, 2023."}],"balance_after":31250,"derivative":{"exercise_price":0,"expiration_date":"2025-05-01","underlying":"Common Stock","underlying_shares":31250},"source":{"system":"sec-edgar","filing":"0001562180-22-003662","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022003662/primarydocument.xml","form_type":"4"}},{"id":2596230,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":23342,"kind":"person","name":"KOCH KEVIN","position":1,"cik":"0001185829","reported_name":"KOCH KEVIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-19T21:09:00.000Z","date":"2021-08-17","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest each month beginning on September 17, 2021, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":400000,"derivative":{"exercise_price":16.38,"expiration_date":"2031-08-17","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001562180-21-005458","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218021005458/primarydocument.xml","form_type":"4"}},{"id":3136807,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":23342,"kind":"person","name":"KOCH KEVIN","position":1,"cik":"0001185829","reported_name":"KOCH KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-05-22T21:16:08.000Z","date":"2020-05-21","kind":"grant","acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Automatic non-discretionary grant to the Reporting Person of a nonstatutory stock option under the Issuer's 2016 Equity Incentive Plan (the \"Plan\") in accordance with the Issuer's Amended and Restated Non-Employee Director Compensation Policy. One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the next annual meeting of the Issuer's stockholders following the date of grant, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":24000,"derivative":{"exercise_price":0.6261,"expiration_date":"2030-05-20","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001209191-20-031830","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185829/000120919120031830/doc4.xml","form_type":"4"}},{"id":3481080,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":23342,"kind":"person","name":"KOCH KEVIN","position":1,"cik":"0001185829","reported_name":"KOCH KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-21T21:16:08.000Z","date":"2019-06-19","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Automatic non-discretionary grant to the Reporting Person of a nonstatutory stock option under the Issuer's 2016 Equity Incentive Plan (the \"Plan\") in accordance with the Issuer's Amended and Restated Non-Employee Director Compensation Policy. One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the next annual meeting of the Issuer's stockholders following the date of grant, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":12000,"derivative":{"exercise_price":2.36,"expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-19-038570","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185829/000120919119038570/doc4.xml","form_type":"4"}},{"id":3881265,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":23342,"kind":"person","name":"KOCH KEVIN","position":1,"cik":"0001185829","reported_name":"KOCH KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-28T20:44:09.000Z","date":"2018-06-27","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Automatic non-discretionary grant to the Reporting Person of a nonstatutory stock option under the Issuer's 2016 Equity Incentive Plan (the \"Plan\") in accordance with the Issuer's Amended and Restated Non-Employee Director Compensation Policy. One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the next annual meeting of the Issuer's stockholders following the date of grant, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":12000,"derivative":{"exercise_price":6.46,"expiration_date":"2028-06-26","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-18-039887","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185829/000120919118039887/doc4.xml","form_type":"4"}},{"id":4269054,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":23342,"kind":"person","name":"KOCH KEVIN","position":1,"cik":"0001185829","reported_name":"KOCH KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-30T21:24:10.000Z","date":"2017-06-28","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Automatic non-discretionary grant to the Reporting Person of a nonstatutory stock option under the Issuer's 2016 Equity Incentive Plan (the \"Plan\") in accordance with the Issuer's Amended and Restated Non-Employee Director Compensation Policy. One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the next annual meeting of the Issuer's stockholders following the date of grant, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":12000,"derivative":{"exercise_price":12.06,"expiration_date":"2027-06-27","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-17-042574","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185829/000120919117042574/doc4.xml","form_type":"4"}}]}